Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tp0751, also known as Pallilysin, is a surface-exposed protein from Treponema pallidum that functions as an adhesin and protease. It binds to ECM proteins and the 67-kDa laminin receptor (LamR) on endothelial cells, facilitating bacterial dissemination. Tp0751 is considered a virulence factor and a potential therapeutic target.
Inhibition of adhesion to ECM components and endothelial receptors; Inhibition of protease activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tp0751 Protein (Pallilysin).